Brain Activity in People With Functional Movement Disorders
BOLD-fMRI of the Perception of Volition in Functional Movement Disorders
2 other identifiers
observational
65
1 country
1
Brief Summary
This study will use functional MRI (fMRI, a technique that shows what areas of the brain are active when performing different mental tasks), to examine how the brain in people with functional movement disorders (FMD) may differ from that in people without FMDs. People with FMD have movement symptoms they feel they cannot control and that are not due to a known medical disorder. Previous studies looking at the brain activity of FMD patients have found areas in the frontal lobe of the brain that appeared overactive. These overactive areas may make it difficult to perform complex mental tasks. Studying the brain during performance of these tasks may enhance knowledge about FMD. Patients 18 years of age or older with an FMD and healthy normal volunteers may be eligible for this study. Participants have two visits to the NIH Clinical Center for the following procedures: First visit (screening):
- Medical history and neurological examination.
- Urine drug screen for illicit drugs.
- Psychological testing, including an interview and questionnaires. Second visit:
- Brain MRI (if one has not been done at NIH within the past 12 months): MRI uses a magnetic field and radio waves to produce images of body tissues and organs. The subject lies on a table that can slide in and out of the scanner (a narrow cylinder), wearing earplugs to muffle loud noises that occur during the scanning process. The procedure lasts about 2 hours, during which time the patient is asked to lie still for up to 30 minutes at a time.
- Brain fMRI: While in the MRI scanner, subjects read questions and answer them yes or no by pushing buttons. They are asked to answer questions about their health, their movement symptoms and unrelated topics (like personal preferences and current events). The questions vary in difficulty. Sometimes subjects are instructed to answer correctly; other times they are asked to answer incorrectly. A strap is placed around the subject's chest and two wires are taped to the fingers to monitor heart rate, breathing rate and sweat response during the scan. The scan takes about 2 hours.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 8, 2007
CompletedFirst Submitted
Initial submission to the registry
March 14, 2007
CompletedFirst Posted
Study publicly available on registry
March 15, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
August 5, 2008
CompletedJuly 2, 2017
August 5, 2008
March 14, 2007
June 30, 2017
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- PATIENTS:
- Age 18 to 65
- Subjects willing to abstain from caffeine or alcohol for 48 hours prior to the fMRI scanning
- Diagnosis of a functional movement disorder confirmed by a study investigator
- HEALTHY VOLUNTEERS:
- \- Age 18 to 65
You may not qualify if:
- Subjects with any abnormal findings on neurological exam consistent with an organic disorder
- Subjects with a positive urine pregnancy test
- Subjects with a positive urine drug screen
- Subjects who are pregnant
- Subjects with any finding on the MRI safety questionnaire which prevents them from safely undergoing an MRI scan
- Subjects with metallic dental fillings which are likely to enhance MRI artifacts
- Subjects with any history of dementia, brain tumor, stroke, head trauma or a vascular malformation as obtained by history or from imaging studies
- Subjects with moderate to severe brain atrophy on imaging studies, as assessed by a study investigator
- Subjects with any history of a severe medical condition, such as cardiovascular disease, which would prevent them from lying flat for up to 120 minutes
- Subjects without the capacity to give informed consent
- Subjects with claustrophobia or other restrictions which prevent them from undergoing a scan in a confined space for up to 120 minutes
- Subjects using beta-blocker medications or other chronotropes which may inhibit the cardiac responsivity
- Patient whose movement frequency and severity prevents them from undergoing MRI safely and effectively for the purposes of data collection
- Patient with a pending medical-legal case
- Subjects with suicidal ideation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Publications (3)
Barry RL, Menon RS. Modeling and suppression of respiration-related physiological noise in echo-planar functional magnetic resonance imaging using global and one-dimensional navigator echo correction. Magn Reson Med. 2005 Aug;54(2):411-8. doi: 10.1002/mrm.20591.
PMID: 16032665BACKGROUNDBash IY, Alpert M. The determination of malingering. Ann N Y Acad Sci. 1980;347:86-99. doi: 10.1111/j.1749-6632.1980.tb21257.x. No abstract available.
PMID: 6930923BACKGROUNDCragar DE, Berry DT, Fakhoury TA, Cibula JE, Schmitt FA. Performance of patients with epilepsy or psychogenic non-epileptic seizures on four measures of effort. Clin Neuropsychol. 2006 Sep;20(3):552-66. doi: 10.1080/13854040590947380.
PMID: 16895866BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
March 14, 2007
First Posted
March 15, 2007
Study Start
March 8, 2007
Study Completion
August 5, 2008
Last Updated
July 2, 2017
Record last verified: 2008-08-05